v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 254,851 $ 225,525
Reconciling items:    
Depreciation 163,004 133,718
Amortization 166,040 143,544
Amortization of non-recoupable ticketing contract advances 54,120 55,893
Amortization of debt issuance costs and discounts, net 16,300 14,765
Non-cash compensation expense 36,924 34,315
Unrealized changes in fair value of contingent consideration 7,372 11,609
Loss (gain) on disposal of operating assets (553) 10,464
Equity in earnings of nonconsolidated affiliates, net of distributions 6,526 10,024
Provision for uncollectible accounts receivable and advances 14,413 16,898
Other, net (9,632) (6,525)
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (392,065) (545,872)
Increase in prepaid expenses and other assets (257,268) (332,254)
Increase in accounts payable, accrued expenses and other liabilities 135,672 484,432
Decrease in deferred revenue (162,782) (960)
Net cash provided by operating activities 32,922 255,576
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances of notes receivable (24,110) (71,578)
Collections of notes receivable 10,142 29,104
Investments made in nonconsolidated affiliates (34,742) (42,580)
Purchases of property, plant and equipment (225,822) (163,714)
Cash paid for acquisitions, net of cash acquired (108,075) (98,288)
Purchases of intangible assets (22,953) (33,175)
Other, net 2,203 1,375
Net cash used in investing activities (403,357) (378,856)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 604 857,121
Payments on long-term debt (30,491) (391,096)
Contributions from noncontrolling interests 13,124 4,900
Distributions to noncontrolling interests (73,182) (41,351)
Purchases and sales of noncontrolling interests, net (29,005) (152,971)
Proceeds from exercise of stock options 13,240 16,447
Taxes paid for net share settlement of equity awards (10,578) (8,685)
Payments for deferred and contingent consideration (23,322) (16,239)
Net Cash Provided by (Used in) Financing Activities, Total (139,610) 268,126
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (59,364) (63,870)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect, Total (569,409) 80,976
Cash, cash equivalents, and restricted cash at beginning of period 2,378,203 1,828,822
Cash, cash equivalents, and restricted cash at end of period $ 1,808,794 $ 1,909,798

Source